Taken together, these results support the potential of GREM1 produced by NSCLC CAFs to engage and phosphorylate the cognate KDR receptor on malignant cells and to induce their proliferation as assessed by KI67 positivity. This evidence concerns the gene GREM1 and non-small cell lung carcinoma.